American Century Companies Inc Inovio Pharmaceuticals, Inc. Transaction History

American Century Companies Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$0.79 - $1.91 $9,867 - $23,855	12,490 Added 25.32%	61,827 $50,000
Q4 2022 Feb 13, 2023	BUY	$1.41 - $2.5 $39,876 - $70,702	28,281 Added 134.31%	49,337 $76,000
Q3 2022 Nov 14, 2022	BUY	$1.66 - $2.79 $34,952 - $58,746	21,056 New	21,056 $36,000
Q2 2019 Aug 14, 2019	SELL	$2.29 - $4.1 $295,643 - $529,318	-129,102 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$3.34 - $5.1 $17,651 - $26,953	5,285 Added 4.27%	129,102 $0
Q4 2018 Feb 13, 2019	BUY	$3.89 - $6.11 $481,648 - $756,521	123,817 New	123,817 $495,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $459M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

Stay updated on American Century Companies Inc with notifications on news.